McNeil Sweden

McNeil Sweden is a prominent entity within the pharmaceutical and healthcare sectors, established in 1914. The company maintains a robust operational footprint with 500-1,000 employees dedicated to advancing medical solutions. Headquartered in Solna, Stockholm, Sweden, the firm leverages its long-standing history to drive innovation in drug development and distribution. McNeil Sweden operates with a focus on high-quality standards, ensuring that its pharmaceutical products meet rigorous industry requirements for safety and efficacy across its target markets.

The organization demonstrates significant scale, reporting annual revenue of $32.3M. This financial performance supports its ongoing commitment to research and development, as well as its operational infrastructure. By maintaining a strategic presence in Europe, the company effectively manages its supply chain and distribution networks to serve diverse patient needs. The firm's commitment to excellence is reflected in its consistent growth and its ability to adapt to the evolving demands of the global healthcare landscape, positioning itself as a reliable partner in the pharmaceutical industry.

Meet McNeil Sweden's team to gain insights into the leadership and professional expertise driving the company's strategic initiatives. With a focus on technical precision and operational efficiency, McNeil Sweden continues to refine its product offerings and expand its influence within the healthcare sector. The company remains dedicated to its core mission of improving health outcomes through scientific rigor and professional excellence, supported by a workforce that prioritizes innovation and quality in every aspect of its pharmaceutical operations.